{
    "2018-11-02": [
        [
            {
                "time": "2018-10-31",
                "original_text": "AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues",
                "features": {
                    "keywords": [
                        "AMAG",
                        "Wider-Than-Expected",
                        "Q3",
                        "Loss",
                        "Beats",
                        "Revenues"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Earnings Estimates Coming Down",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Estimates",
                        "Coming",
                        "Down"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss",
                "features": {
                    "keywords": [
                        "Radius",
                        "Health",
                        "RDUS",
                        "Narrower-Than-Expected",
                        "Q3",
                        "Loss"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise",
                "features": {
                    "keywords": [
                        "Teva",
                        "TEVA",
                        "Q3",
                        "Earnings",
                        "Beat",
                        "2018",
                        "EPS",
                        "View",
                        "Up",
                        "Shares",
                        "Rise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "A Look at Merck’s Diabetes and Women’s Health Business",
                "features": {
                    "keywords": [
                        "Merck",
                        "Diabetes",
                        "Women’s",
                        "Health",
                        "Business"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "PFE",
                        "AGN",
                        "Q3",
                        "Earnings",
                        "LLY",
                        "NVS",
                        "Collaboration",
                        "Deals",
                        "Focus"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}